Registry-based study on the effect and safety of Firehawk™and Firehawk Liverty™ stent for coronary atherosclerotic lesions

Harmonizing Optimal Strategy for Treatment of coronary atherosclerotic lesions – Registry-based study on the effect and safety of Firehawk™and Firehawk Liverty™, Sirolimus-eluting stent for coronary atherosclerotic lesions

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

CRIS

Registry ID

KCT0006491

Enrollment

1000

Registered

2021-08-24

Start date

2018-10-11

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Hospital

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Over 19 years of age who has been treated with a Firehawk™ and Firehawk Liverty™ stent for coronary artery disease who has agreed in writing to participate in this registry study

Exclusion criteria

Exclusion criteria: There is no exclusion criteria in this study.

Design outcomes

Primary

Measure	Time frame
combined clinical events of Death, Myocardial infarction and Target Vessel Revascularization(TVR)	—

Secondary

Measure	Time frame
cardiogenic death;myocardial infarction;stent thrombosis;bleeding events	—

Countries

Korea, Republic of

Contacts

Public ContactChan Soon Park

Seoul National University Hospital

shiny365@hanmail.net+82-2-2072-3757

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026